Your browser doesn't support javascript.
loading
Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition.
Ai, Xiangzhao; Wang, Dan; Honko, Anna; Duan, Yaou; Gavrish, Igor; Fang, Ronnie H; Griffiths, Anthony; Gao, Weiwei; Zhang, Liangfang.
Afiliación
  • Ai X; Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
  • Wang D; Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
  • Honko A; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
  • Duan Y; Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
  • Gavrish I; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
  • Fang RH; Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
  • Griffiths A; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
  • Gao W; Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
  • Zhang L; Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
J Am Chem Soc ; 143(42): 17615-17621, 2021 10 27.
Article en En | MEDLINE | ID: mdl-34647745

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polisacáridos / Heparina / Nanoestructuras / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polisacáridos / Heparina / Nanoestructuras / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos